Jane Street’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Sell
36,100
-260,400
-88% -$1.73M ﹤0.01% 10036
2026
Q1
$2.15M Buy
296,500
+138,000
+87% +$1.8M ﹤0.01% 4950
2025
Q4
$2.69M Buy
158,500
+100,000
+171% +$1.02M ﹤0.01% 4245
2025
Q3
$428K Buy
58,500
+42,600
+268% +$345K ﹤0.01% 8190
2025
Q2
$103K Sell
15,900
-19,900
-56% -$131K ﹤0.01% 8933
2025
Q1
$289K Sell
35,800
-12,000
-25% -$131K ﹤0.01% 7866
2024
Q4
$591K Buy
+47,800
New +$638K ﹤0.01% 6419
2024
Q1
Sell
-26,900
Closed -$136K 10197
2023
Q4
$136K Buy
+26,900
New +$144K ﹤0.01% 8441
2022
Q2
Sell
-14,600
Closed -$29K 11050
2022
Q1
$29K Sell
14,600
-500
-3% -$1.23K ﹤0.01% 9845
2021
Q4
$47K Buy
+15,100
New +$62.7K ﹤0.01% 9557
2021
Q2
Sell
-31,100
Closed -$174K 10503
2021
Q1
$174K Buy
+31,100
New +$299K ﹤0.01% 8361
2020
Q4
Sell
-94,600
Closed -$803K 8204
2020
Q3
$803K Buy
+94,600
New +$1.04M ﹤0.01% 4450
2020
Q1
Sell
-27,200
Closed -$218K 6078
2019
Q4
$218K Buy
+27,200
New +$667K ﹤0.01% 4642

Other funds holding WVE

Jane Street's WVE Position: Q1 2026 in Review

Jane Street sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 110,924 shares — an estimated $1.45M sold.

Jane Street first reported a position in WVE in Q3 2018 and held it in 15 quarters. The position peaked at $4.54M in Q3 2025. 232 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Jane Street reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 110,924 Wave Life Sciences shares in Q1 2026, an estimated $1.45M.
  • Jane Street first reported a position in Wave Life Sciences in Q3 2018 and held it in 15 quarters.
  • Jane Street's Wave Life Sciences position peaked at $4.54M in Q3 2025.
  • 232 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.